Ilex Capital Partners (UK) LLP

Position in A — Agilent Technologies, Inc.

CIK 1985486 London, X0

Position in A

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$137,511,057

+$17,422,615 QoQ

Shares Held

1,206,449

+36.7% QoQ

Ownership

0.427%

of shares outstanding

% of Portfolio

3.39%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ilex Capital Partners (UK) LLP holds $222,464,235 across 5 Diagnostics & Research names.

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	154,736	$77,578,440
2	IQV	Iqvia Holdings Inc.	370,977	$71,680,175
3	ILMN	Illumina, Inc.	289,131	$50,837,903
4	CRL	Charles River Laboratories International, Inc.	81,193	$18,413,760
5	RVTY	Revvity, Inc.	35,538	$3,953,957

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$137,511,057	1,206,449	+36.7%	Shares	Sole	2026-05-15
2025-12-31	$120,088,442	882,549	+39.5%	Shares	Sole	2026-02-17
2025-09-30	$81,216,927	632,777	-22.8%	Shares	Sole	2025-11-14
2025-06-30	$96,684,412	819,290	+218.8%	Shares	Sole	2025-08-14
2024-12-31	$34,521,618	256,972	+15.3%	Shares	Sole	2025-02-14
2024-09-30	$33,086,689	222,836	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.